Notable Labs Price to Sales Ratio 2013-2024 | NTBLQ
Historical PS ratio values for Notable Labs (NTBLQ) over the last 10 years. The current P/S ratio for Notable Labs as of October 24, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Notable Labs P/S Ratio Historical Data |
Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
2024-10-22 |
0.25 |
|
768.93 |
2024-06-30 |
0.63 |
$0.00 |
0.00 |
2024-03-31 |
1.77 |
$0.00 |
0.00 |
2023-12-31 |
1.89 |
0 |
0.00 |
2023-09-30 |
8.55 |
$-0.99 |
0.00 |
2023-06-30 |
8.05 |
$-0.77 |
0.00 |
2023-03-31 |
5.86 |
$-0.75 |
0.00 |
2022-12-31 |
4.20 |
$-0.69 |
0.00 |
2022-09-30 |
5.44 |
$0.40 |
13.58 |
2022-06-30 |
56.35 |
$0.28 |
199.66 |
2022-03-31 |
59.15 |
$0.35 |
169.07 |
2021-12-31 |
68.95 |
$0.42 |
163.03 |
2021-09-30 |
71.75 |
$0.48 |
148.31 |
2021-06-30 |
83.65 |
$0.53 |
159.13 |
2021-03-31 |
70.00 |
$0.56 |
125.31 |
2020-12-31 |
66.15 |
$0.79 |
83.85 |
2020-09-30 |
42.70 |
$0.75 |
57.12 |
2020-06-30 |
44.80 |
$0.68 |
65.53 |
2020-03-31 |
47.25 |
$0.69 |
68.61 |
2019-12-31 |
42.00 |
$0.55 |
76.69 |
2019-09-30 |
47.25 |
$0.57 |
82.26 |
2019-06-30 |
45.50 |
$0.60 |
76.36 |
2019-03-31 |
53.20 |
$0.67 |
79.38 |
2018-12-31 |
33.95 |
$0.65 |
52.44 |
2018-09-30 |
56.88 |
$0.50 |
114.22 |
2018-06-30 |
77.00 |
$0.40 |
192.76 |
2018-03-31 |
80.50 |
$0.19 |
422.16 |
2017-12-31 |
248.50 |
0 |
0.00 |
2017-09-30 |
213.50 |
0 |
0.00 |
2017-06-30 |
155.75 |
0 |
0.00 |
2017-03-31 |
192.50 |
0 |
0.00 |
2016-12-31 |
169.75 |
0 |
0.00 |
2016-09-30 |
182.70 |
0 |
0.00 |
2016-06-30 |
161.35 |
0 |
0.00 |
2016-03-31 |
121.80 |
0 |
0.00 |
2015-12-31 |
184.10 |
0 |
0.00 |
2015-09-30 |
261.80 |
0 |
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|